BioAtla, Inc. (BCAB) reporting calendar
BioAtla, Inc. files periodic reports with the SEC as BCAB on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 14 Jul 2026 – 6 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 15 May 2026
- Reports on record
- 22
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open BCAB market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 15 May 2026 | 45 days | 0001193125-26-226631 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001193125-26-134499 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001193125-25-280435 |
| 10-Q | 30 Jun 2025 | 7 Aug 2025 | 38 days | 0000950170-25-105220 |
| 10-Q | 31 Mar 2025 | 6 May 2025 | 36 days | 0000950170-25-064594 |
| 10-K | 31 Dec 2024 | 28 Mar 2025 | 87 days | 0000950170-25-046217 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0000950170-24-123506 |
| 10-Q | 30 Jun 2024 | 8 Aug 2024 | 39 days | 0000950170-24-094164 |
| 10-Q | 31 Mar 2024 | 14 May 2024 | 44 days | 0000950170-24-059757 |
| 10-K | 31 Dec 2023 | 26 Mar 2024 | 86 days | 0000950170-24-036548 |
| 10-Q | 30 Sep 2023 | 7 Nov 2023 | 38 days | 0000950170-23-060389 |
| 10-Q | 30 Jun 2023 | 1 Aug 2023 | 32 days | 0000950170-23-036554 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0000950170-23-021358 |
| 10-K | 31 Dec 2022 | 23 Mar 2023 | 82 days | 0000950170-23-009551 |
| 10-Q | 30 Sep 2022 | 4 Nov 2022 | 35 days | 0000950170-22-022036 |
| 10-Q | 30 Jun 2022 | 9 Aug 2022 | 40 days | 0000950170-22-016149 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0000950170-22-007871 |
| 10-K | 31 Dec 2021 | 28 Feb 2022 | 59 days | 0000950170-22-002303 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0000950170-21-004617 |
| 10-Q | 30 Jun 2021 | 13 Aug 2021 | 44 days | 0000950170-21-001443 |
| 10-Q | 31 Mar 2021 | 12 May 2021 | 42 days | 0000950170-21-000192 |
| 10-K | 31 Dec 2020 | 24 Mar 2021 | 83 days | 0001193125-21-092812 |
Source: SEC EDGAR company submissions for CIK 0001826892. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.